MedPath

The Efficacy of Self-MONitoring of blood glucose in patients with type two diabetes mellitus

Completed
Conditions
Type two diabetes mellitus
Nutritional, Metabolic, Endocrine
Non-insulin-dependent diabetes mellitus
Registration Number
ISRCTN49814766
Lead Sponsor
niversity of Ulster (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
200
Inclusion Criteria

1. Patients with newly diagnosed type two diabetes
2. Aged less than 70 years old

Exclusion Criteria

1. Secondary diabetes
2. Insulin use
3. Previous monitoring
4. Pregnancy
5. Previous malignancy
6. Major illness within 6 months (including major surgery, myocardial infarction (MI), acute coronary syndrome, stroke, acute limb ischaemia)
7. Liver disease
8. Creatinine > 150 µmol/L
9. Proteinuria > 0.5 g/ 24 h
10. Chronic use of oral steroids
11. Alcohol abuse

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Between-group differences in glycaemic control (HbA1c)<br>2. Between-group differences in psychological indices<br>3. Between-group differences in reported hypoglycaemia
Secondary Outcome Measures
NameTimeMethod
1. Between-group differences in body mass index (BMI)<br>2. Between-group differences in oral hypoglycaemic drug usage<br>3. Longitudinal within-group changes in HbA1c, BMI and psychological indices
© Copyright 2025. All Rights Reserved by MedPath